AUDIT MicroControls, Inc. Announces Control FLQ Vitamin D

Date: June 20, 2024


June 20, 2024 (Eatonton, GA) - AUDIT MicroControls, Inc. is pleased to announce the following new addition to our line of calibration verification/linearity and daily quality control products: Control FLQ Vitamin D. It is intended to simulate human patient samples for the purpose of monitoring the precision of laboratory testing procedures for Vitamin D assays. When used for quality control purposes, it is recommended that each laboratory establish its own means and acceptable ranges and use the values provided only as guides.


The Control FLQ Vitamin D, Order Number K082M-10, is for In Vitro Diagnostic use only. The Control FLQ Vitamin D is an assayed, stable, bi-level reference control for use with assays designed to quantitate Vitamin D. This product has an open vial stability of up to 30 days when stored at 2-8°C.


AUDIT MicroControls provides Auditor QC, a free online, real-time data reduction program that offers Levey-Jennings charts and peer group analysis for daily quality control product users, as well as linearity graphs and peer group analysis. Report results are given immediately in an “inspector friendly format” and stored on the Auditor QC website for future reference.


AUDIT is the only total solution in linearity/calibration verification and daily quality control materials for clinical laboratories. AUDIT provides value to customers through high-quality products, easy-to-use data management tools, and unrivaled personalized service. Our partnership with Aalto Scientific, a leader in manufacturing and supply for more than forty years, enables us to offer significant cost-savings. This synergistic partnership means our customers benefit from a broad line of superior solutions that address the challenges faced by today’s labs. By better understanding our customers’ needs, AUDIT can find ways to make life in the lab a little easier.


For more information about AUDIT, please call (866) 25-AUDIT or visit To connect via social media, please visit,, and